The use of phosphodiesterase type 5 inhibitors for erectile dysfunction

Curr Opin Urol. 2004 Nov;14(6):357-9. doi: 10.1097/00042307-200411000-00011.
No abstract available

Publication types

  • Review

MeSH terms

  • 3',5'-Cyclic-GMP Phosphodiesterases
  • Cyclic Nucleotide Phosphodiesterases, Type 5
  • Erectile Dysfunction / drug therapy*
  • Humans
  • Male
  • Phosphodiesterase Inhibitors / therapeutic use*
  • Phosphoric Diester Hydrolases

Substances

  • Phosphodiesterase Inhibitors
  • Phosphoric Diester Hydrolases
  • 3',5'-Cyclic-GMP Phosphodiesterases
  • Cyclic Nucleotide Phosphodiesterases, Type 5
  • PDE5A protein, human